A comprehensive approach to reduce harm for people who inject drugs
Official title: In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs
Funded at University of Miami School of Medicine · NIH-11082326 · Data updated 2026-11-12
This study is creating a friendly program to help people who inject drugs by offering easy access to important health services like HIV testing and clean syringes, all in a supportive environment that understands their challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | June 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $627,298 |
| NIH project number | 5R01DA058352-03 |
| Project ID | NIH-11082326 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who inject drugs and are at risk for HIV and other related health conditions.
✕Less likely to help
Patients who do not inject drugs or are not at risk for HIV may not benefit from this research.
What this research studies
This research aims to develop and test a comprehensive tele-harm reduction program specifically designed for people who inject drugs (PWID). It focuses on integrating various healthcare services, including rapid HIV testing, antiretroviral therapy, and syringe services, into a single, accessible model. The program will be implemented in supportive environments that address the stigma and discrimination faced by PWID, while also tackling related health issues such as hepatitis C and overdose. By utilizing a hybrid effectiveness-implementation trial, the research seeks to evaluate the feasibility and acceptability of this approach among the target population.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV infections and improve overall health outcomes for people who inject drugs.
How similar studies have gone: Previous research has shown success with integrated healthcare models for PWID, indicating potential for this comprehensive approach.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Tookes, Hansel Emory — University of Miami School of Medicine
- Study coordinator: Tookes, Hansel Emory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.